See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Licensing for novel engineering of a blood-stage malaria vaccine based on the Plasmodium falciparum merozoite surface protein 1, MSP1
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-2897-9a5d-cec9-714480000000
Resource Type
Properties
-
-
Resource Description
-
"The Plasmodium falciparum malaria parasite protein - MSP1-42 - is being tested in clinical trials as a malaria vaccine, however, although MSP1-42 has been demonstrated to be immunogenic, it is not protective against malaria."
-
-
Contact
-
Park, Ann
-
-
Service Provided by
-
Office of Technology Transfer and Economic Development (OTTED)
-
-
Website(s)
-
http://www.otted.hawaii.edu/technology/00768/novel-engineering-blood-stage-malaria-vaccine-based-teh-plasmodium-falciparum-meroz
